Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

Targeted biologics have revolutionised the treatment and outlook of patients with inflammatory joint diseases. The combination of high-cost long-term therapy straining healthcare systems with impending expiry of key biologics patents has led to heightened interest in the development of biosimilars....

Cijeli opis

Bibliografski detalji

Glavni autori:	Edward Keystone, Leigh Revers, Thomas Dörner
Format:	Artigo
Jezik:	Inglês
Izdano:	European Medical Journal 2016-07-01
Serija:	European Medical Journal Rheumatology
Teme:	EULAR European League Against Rheumatism
Online pristup:	http://emjreviews.com/wp-content/uploads/Unravelling-the-Mystery-Between-Structure-and-Sustained-Clinical-Outcomes.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!